T Skevas1, C Klingmann, P K Plinkert, I Baumann. 1. HNO-Klinik, Krankenanstalt "Mutterhaus der Borromäerinnen", Akademisches Lehrkrankenhaus der Universität Mainz, Trier, Deutschland. theodoros.skevas@mutterhaus.de
Abstract
BACKGROUND: Until now, no validated instrument to measure disease-specific, health-related quality of life (HR-QOL) in adults with chronic tonsillitis (CTO) exists. MATERIAL AND METHODS: After an item reduction of the alpha-version of the Tonsillectomy Outcome Inventory (TOI), the TOI-14 resulted. In addition to the total score, it includes the subscales throat problems, overall health, resources, and social-psychological restrictions. In phase 2, the TOI-14 was prospectively validated on 108 adults with CTO, who had undergone a tonsillectomy. RESULTS: The TOI-14 had, on average, good reliability. It included all important aspects of the HR-QOL. Patients with CTO can be distinguished with high sensitivity from healthy subjects. All scores showed moderate to good correlation with the subjective limitation in quality of life. The sensitivity of the questionnaire demonstrated major effects postoperatively. CONCLUSION: The TOI-14 constitutes the first worldwide-validated, disease-specific instrument to measure HR-QOL in adults with CTO. Due to its ease of use, it can be utilized both in the outcome research and in clinical routine.
BACKGROUND: Until now, no validated instrument to measure disease-specific, health-related quality of life (HR-QOL) in adults with chronic tonsillitis (CTO) exists. MATERIAL AND METHODS: After an item reduction of the alpha-version of the Tonsillectomy Outcome Inventory (TOI), the TOI-14 resulted. In addition to the total score, it includes the subscales throat problems, overall health, resources, and social-psychological restrictions. In phase 2, the TOI-14 was prospectively validated on 108 adults with CTO, who had undergone a tonsillectomy. RESULTS: The TOI-14 had, on average, good reliability. It included all important aspects of the HR-QOL. Patients with CTO can be distinguished with high sensitivity from healthy subjects. All scores showed moderate to good correlation with the subjective limitation in quality of life. The sensitivity of the questionnaire demonstrated major effects postoperatively. CONCLUSION: The TOI-14 constitutes the first worldwide-validated, disease-specific instrument to measure HR-QOL in adults with CTO. Due to its ease of use, it can be utilized both in the outcome research and in clinical routine.
Authors: David L Witsell; Laura J Orvidas; Michael G Stewart; Maureen T Hannley; Edward M Weaver; Bevan Yueh; Timothy L Smith; Nira A Goldstein Journal: Otolaryngol Head Neck Surg Date: 2008-01 Impact factor: 3.497
Authors: Ingo Baumann; Hanka Kucheida; Gunnar Blumenstock; Ilse M Zalaman; Marcus M Maassen; Peter K Plinkert Journal: Eur Arch Otorhinolaryngol Date: 2006-02-21 Impact factor: 2.503
Authors: Ilona Schwentner; Stefan Höfer; Joachim Schmutzhard; Martina Deibl; Georg M Sprinzl Journal: Swiss Med Wkly Date: 2007-08-11 Impact factor: 2.193
Authors: Isabel Rubie; Catherine Haighton; James O'Hara; Nikki Rousseau; Nick Steen; Deborah D Stocken; Frank Sullivan; Luke Vale; Scott Wilkes; Janet Wilson Journal: Trials Date: 2015-06-06 Impact factor: 2.279
Authors: Jan Löhler; B Akcicek; F Müller; G Dreier; J J Meerpohl; W Vach; J A Werner Journal: GMS Curr Top Otorhinolaryngol Head Neck Surg Date: 2016-12-15